Feature Channels: Diabetes

Filters close
Newswise: Ohio State Receives $12 Million to Study Effectiveness of Therapies for Gestational Diabetes
Released: 18-Jul-2023 11:05 AM EDT
Ohio State Receives $12 Million to Study Effectiveness of Therapies for Gestational Diabetes
Ohio State University Wexner Medical Center

Gestational diabetes is on the rise among pregnant people, and now Ohio State University Wexner Medical Center has received a $12 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to define the best treatment. The study will compare oral metformin versus injectable insulin.

Released: 14-Jul-2023 1:05 PM EDT
Exercise during dialysis has positive health impact
Technical University of Munich

Patients who engage in light exercise while undergoing dialysis are physically fitter and are admitted to hospital less frequently than those who do not.

Released: 12-Jul-2023 11:35 AM EDT
Historical medicine suggests a new way to use modern treatments
Microbiology Society

The mixture of honey and vinegar, also known as oxymel, has been used as a medical treatment throughout history and now scientists have established that this combination could have modern applications in the treatment of wounds. New research is the first comprehensive exploration of how the mixture could be applied to modern medicine and improve treatments for infections.

Newswise: Weekly insulin found safe, effective for Type 2 diabetes
Released: 12-Jul-2023 10:40 AM EDT
Weekly insulin found safe, effective for Type 2 diabetes
UT Southwestern Medical Center

An experimental form of insulin administered just once a week was safe for patients with Type 2 diabetes and helped them maintain healthy blood sugar levels better than insulin injected daily, according to the results of a phase 3 clinical trial led by a UT Southwestern Medical Center researcher.

Newswise: ‘Just breathe’: Missouri S&T researchers ready for clinical trials for diagnostic instrument
Released: 11-Jul-2023 4:20 PM EDT
‘Just breathe’: Missouri S&T researchers ready for clinical trials for diagnostic instrument
Missouri University of Science and Technology

When an ill person schedules a doctor visit, blood work or other diagnostic testing is often required before a diagnosis is determined. Missouri University of Science and Technology electrical engineering researcher Dr. Jie Huang is developing technology that would allow patients to “just breathe” and avoid that testing.

   
Newswise: Neurons that track, regulate blood-sugar levels are found
Released: 11-Jul-2023 1:45 PM EDT
Neurons that track, regulate blood-sugar levels are found
University of Washington School of Medicine

Understanding how this blood-sugar detection system works and how these neurocircuits operate would give researchers and doctors greater insights into how our brains regulate our blood sugar and, perhaps, how to target them therapeutically to treat metabolic diseases like diabetes and obesity, according to the study authors.

Newswise: Gene that regulates immune activity in the retina identified
Released: 11-Jul-2023 11:25 AM EDT
Gene that regulates immune activity in the retina identified
UT Southwestern Medical Center

UT Southwestern Medical Center researchers have identified a gene called Lipe that appears to be pivotal to retinal health, with mutations spurring immune activation and retinal degeneration. This is important because the retina is responsible for detecting the light that is transformed into vision. The findings, published in Communications Biology, provide clues about the mechanisms behind a variety of disorders affecting the retina, including macular degeneration and diabetic retinopathy.

Newswise: Metabolic Syndrome Risk Doubled from Adolescence to Young Adulthood
Released: 11-Jul-2023 8:05 AM EDT
Metabolic Syndrome Risk Doubled from Adolescence to Young Adulthood
American Physiological Society (APS)

Risk of metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke and Type 2 diabetes, doubled in people during the growth period from adolescence to young adulthood.

Released: 7-Jul-2023 11:20 AM EDT
Researchers uncover how a genetic mutation can cause individuals with normal cholesterol levels to develop coronary artery disease at a young age
University of Texas Health Science Center at Houston

A novel molecular pathway to explain how a mutation in the gene ACTA2 can cause individuals in their 30s – with normal cholesterol levels and no other risk factors — to develop coronary artery disease has been identified, according to researchers with UTHealth Houston.

Newswise: Produce Prescription Programs for Patients with Diabetes Could Save Billions in Healthcare Costs, Study Shows
Released: 7-Jul-2023 8:20 AM EDT
Produce Prescription Programs for Patients with Diabetes Could Save Billions in Healthcare Costs, Study Shows
Tufts University

A modeled implementation of a nationwide produce prescription program—which would provide free or discounted fruits and vegetables to eligible Americans living with diabetes —projected extensive reductions in national rates of cardiovascular disease and associated healthcare costs.

Newswise: The Medical Minute: Early detection key to protecting vision from glaucoma
Released: 6-Jul-2023 8:35 AM EDT
The Medical Minute: Early detection key to protecting vision from glaucoma
Penn State Health

Glaucoma can develop for years before you experience a symptom. A Penn State Health optometrist discusses early diagnosis and how testing can make all the difference for your vision.

Released: 3-Jul-2023 9:00 AM EDT
Endocrine Society’s Journal of the Endocrine Society earns first Impact Factor
Endocrine Society

The Endocrine Society’s Journal of the Endocrine Society (JES) received its first Impact Factor score in 2022, while the Society’s other journals maintained high rankings on the prestigious measure of scholarly publishing.

   
Released: 29-Jun-2023 11:55 AM EDT
Patients Taking Popular Medications for Diabetes and Weight Loss Should Stop Before Elective Surgery, ASA Suggests
American Society of Anesthesiologists (ASA)

With the growing popularity of medications like Ozempic® (semaglutide), Trulicity® (dulaglutide), and other glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes and weight loss, the American Society of Anesthesiologists (ASA) suggests withholding the medication before elective surgery to reduce the risk of complications associated with anesthesia in adults and children.

Newswise:Video Embedded proteins-predict-significant-step-toward-development-of-diabetes
VIDEO
28-Jun-2023 3:00 PM EDT
Proteins Predict Significant Step Toward Development of Diabetes
Pacific Northwest National Laboratory

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

Released: 28-Jun-2023 3:05 PM EDT
For Type 2 Diabetics Who Exercise, Some Approaches Are Better Than Others
Rutgers University-New Brunswick

An analysis on the positive effects of exercise on blood sugar levels in people with Type 2 diabetes shows that while all exercise helps, certain activities – and their timing – are extremely good for people’s health. The study, published in The American Journal of Medicine, provides a comprehensive but straightforward summary of the benefits of exercise on controlling blood glucose levels in people with Type 2 diabetes.

Newswise: McMaster University team discovers hormonal pathway that increases calorie burning during weight loss
26-Jun-2023 12:15 PM EDT
McMaster University team discovers hormonal pathway that increases calorie burning during weight loss
McMaster University

The research team studied a hormone called GDF15 that they had previously shown to reduce appetite in response to the type 2 diabetes drug metformin. It was discovered that in mice, GDF15 blocks the slowing of metabolism that occurs during dieting by ramping up calcium futile cycling in muscle.

22-Jun-2023 10:30 AM EDT
Light or moderate alcohol consumption does not guard against diabetes, obesity
Endocrine Society

People who have just one or two drinks per day are not protected against endocrine conditions such as obesity and type 2 diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

26-Jun-2023 8:25 AM EDT
Cooperation between muscle and liver circadian clocks, key to controlling glucose metabolism
Institute for Research in Biomedicine Barcelona

Collaborative work by teams at the Department of Medicine and Life Sciences (MELIS) ​​at Pompeu Fabra University (UPF), University of California, Irvine (UCI), and the Institute for Research in Biomedicine (IRB Barcelona) has shown that interplay between circadian clocks in liver and skeletal muscle controls glucose metabolism.

Newswise: Higher Doses of Oral Semaglutide Improves Blood Sugar Control and Weight Loss
Released: 26-Jun-2023 5:05 PM EDT
Higher Doses of Oral Semaglutide Improves Blood Sugar Control and Weight Loss
University of North Carolina Health Care System

John Buse, MD, PhD, the Verne S. Caviness Distinguished Professor of Medicine in the Division of Endocrinology and Metabolism, and an international team of researchers have presented new findings about new higher-dose formulations of oral semaglutide. Their study found that once-daily oral semaglutide taken at 25 mg and 50 mg did a better job in lowering blood sugar levels and promoting weight loss than the lowest dose of 14 mg.

Newswise: Validation Institute Confirms Over $2,200 per member per year savings from Ochsner Digital Medicine
Released: 26-Jun-2023 3:05 PM EDT
Validation Institute Confirms Over $2,200 per member per year savings from Ochsner Digital Medicine
Ochsner Health

Ochsner Digital Medicine has achieved Validation for Savings by the Validation Institute, an independent non-profit organization. The Institute confirmed in a new propensity-matched study that members of Ochsner Connected Health’s chronic disease management program have lower per member per month costs than similar non-participants.

   
Newswise: Defective closure of diabetic foot ulcers is associated with higher risk of wound recurrence
Released: 26-Jun-2023 2:05 PM EDT
Defective closure of diabetic foot ulcers is associated with higher risk of wound recurrence
Indiana University

Results from a new study of diabetic foot ulcers and the risk of wound recurrence show that a new approach can help health care workers measure the likelihood that the wound will reopen in the future.

Released: 21-Jun-2023 9:00 AM EDT
Nationwide Children’s Hospital Marks A Decade as One of the Nation’s Best
Nationwide Children's Hospital

Nationwide Children’s Hospital has been named to U.S. News & World Report’s Best Children’s Hospitals Honor Roll for the 10th consecutive year. The Honor Roll is a top distinction awarded to only 10 children’s hospitals nationwide recognized by U.S. News as the “Best of the Best.” Nationwide Children’s is ranked sixth on the 2023-24 Honor Roll list.

Newswise: UCSF Internal Medicine Specialist to be Celebrated for Diabetes Epidemiology Research
Released: 21-Jun-2023 8:00 AM EDT
UCSF Internal Medicine Specialist to be Celebrated for Diabetes Epidemiology Research
University of California, San Francisco (UCSF)

Alka M. Kanaya, MD, UC San Francisco primary care physician and researcher, is being recognized with the 2023 Kelly West Award for Outstanding Achievement in Epidemiology from the American Diabetes Association (ADA). The award recognizes significant contributions to the field of diabetes epidemiology.

Newswise: Postpartum morbidity and mortality in women with epilepsy: A 28-year study
Released: 19-Jun-2023 12:05 PM EDT
Postpartum morbidity and mortality in women with epilepsy: A 28-year study
International League Against Epilepsy

A 28-year study found increased risks of preeclampsia, gestational diabetes, ICU admission during hospitalization for delivery, postpartum hospitalization, and an increased risk of mortality compared with pregnant women who did not have epilepsy.

8-Jun-2023 9:40 AM EDT
Radioactive iodine or surgery associated with increased survival in hyperthyroidism
Endocrine Society

Hyperthyroidism treatment like radioactive iodine or surgery was associated with a decreased risk for death, according to research being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago.

8-Jun-2023 10:15 AM EDT
Closed-loop insulin delivery systems may improve blood sugar control in children with type 1 diabetes
Endocrine Society

Closed-loop insulin delivery systems improve glucose control in children with type 1 diabetes without causing adverse effects, according to a study presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

8-Jun-2023 10:05 AM EDT
Prevalence of metabolic associated fatty liver disease is increasing
Endocrine Society

The percent of metabolic associated fatty liver disease (MAFLD), the leading global cause of liver disease, is increasing in U.S. adults, according to a study presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

8-Jun-2023 9:45 AM EDT
Growing number of hypothyroidism patients receiving treatment other than levothyroxine
Endocrine Society

The use of thyroid hormones other than the commonly prescribed hormone medicine levothyroxine to treat hypothyroidism, or underactive thyroid, is increasing, according to a study being presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

13-Jun-2023 5:25 PM EDT
Endocrine Society Scientific Statement distinguishes normal aging from endocrine disease
Endocrine Society

A new Scientific Statement released today by the Endocrine Society highlights the differences between aspects of aging that are normal and sometimes over-treated, and those such as menopausal symptoms and osteoporosis that can be treated and deserve more attention.

8-Jun-2023 10:10 AM EDT
Low food security linked to metabolic syndrome in reproductive-aged Latinx females
Endocrine Society

Not having reliable access to food has a significant relationship with metabolic syndrome, a condition that increases risk for diseases such as diabetes and heart disease, in Latinx females of reproductive age, according to a study presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

12-Jun-2023 9:35 AM EDT
Early time-restricted feeding improves blood sugar levels
Endocrine Society

Early-time restricted feeding, a type of intermittent fasting, improved fluctuations in blood glucose levels and decreased time above range, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

8-Jun-2023 9:35 AM EDT
Gestational diabetes cases increased during the COVID-19 pandemic
Endocrine Society

More pregnant women developed gestational diabetes during the COVID-19 pandemic than in the preceding two years, according to research being presented on Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

9-Jun-2023 10:05 AM EDT
CGM alarms often not set to alert children with diabetes to harmful blood glucose fluctuations
Endocrine Society

Children and teenagers who use continuous glucose monitors (CGM) to manage diabetes often fail to use the appropriate alarm settings to alert to dangerously low or harmful high blood sugar levels, according to a study being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill. This variability makes the monitors less useful in tracking glucose levels.

8-Jun-2023 10:15 AM EDT
Many people with type 1 diabetes continue to struggle to control blood sugar surrounding exercise
Endocrine Society

Many people with type 1 diabetes struggle to exercise safely while keeping their blood sugar levels within a healthy range, according to a study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

8-Jun-2023 10:10 PM EDT
Duration and poor quality of sleep associated with greater risk for diabetes
Endocrine Society

Fewer than six hours or more than 10 hours of sleep, and poor quality of sleep are associated with a greater risk for diabetes, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

8-Jun-2023 10:05 AM EDT
Type 2 diabetes increased among youth during and after COVID-19 pandemic
Endocrine Society

The number of children diagnosed with type 2 diabetes continued to rise in the year following the beginning of the COVID-19 pandemic, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

8-Jun-2023 10:10 AM EDT
Breastfeeding may help mothers avoid type 2 diabetes
Endocrine Society

Breastfeeding can improve the number of insulin-producing cells in the pancreas and increase insulin sensitivity in mothers, helping to protect them against type 2 diabetes in later years, suggests a mice study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

8-Jun-2023 10:05 AM EDT
Teens with type 1 diabetes who see a pediatrician longer may have a smoother transition to adult care
Endocrine Society

Keeping adolescents with type 1 diabetes in pediatric diabetes care until at least age 17 may increase the chance that they will have a successful transition to adult care, according to a study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

8-Jun-2023 9:00 AM EDT
Body image concerns significantly higher in women living with PCOS
Endocrine Society

Women living with polycystic ovary syndrome (PCOS) experience greater body image concerns than individuals without the condition, according to research being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Newswise: Machine-learning method used for self-driving cars could improve lives of type-1 diabetes patients
13-Jun-2023 6:05 AM EDT
Machine-learning method used for self-driving cars could improve lives of type-1 diabetes patients
University of Bristol

The same type of machine learning methods used to pilot self-driving cars and beat top chess players could help type-1 diabetes sufferers keep their blood glucose levels in a safe range.

   
Released: 14-Jun-2023 2:15 PM EDT
Remission rates of 1 in 100 people with type 2 diabetes in real world data
Niigata University

The phenomenon of improvement of glucose to levels in a normal range and cessation of the need for medication can occur in some patients diagnosed with type 2 diabetes who are provided with lifestyle therapy, temporary pharmacotherapy, bariatric surgery, or combinations of these treatments.

Newswise: Black patients with plaque build-up in arteries in the legs more likely to have a stroke, heart attack or amputation than white patients
Released: 13-Jun-2023 12:05 PM EDT
Black patients with plaque build-up in arteries in the legs more likely to have a stroke, heart attack or amputation than white patients
Keck Medicine of USC

A new study from Keck Medicine of USC has uncovered significant racial disparities in the diagnosis, treatment and outcomes of peripheral artery disease (PAD) among Black and white patients in the United States.

Not for public release

This news release is embargoed until 12-Jun-2023 5:00 PM EDT Released to reporters: 6-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Lots of water, small dietary changes can help prevent kidney stones, UTSW expert says
Released: 12-Jun-2023 1:30 PM EDT
Lots of water, small dietary changes can help prevent kidney stones, UTSW expert says
UT Southwestern Medical Center

The painful experience of having a kidney stone has become more common in recent years, including in Texas, part of the “Stone Belt” where hot weather can cause dehydration. But small dietary changes as well as drinking lots of water can help avert the discomfort, says a board-certified physician assistant in the Department of Urology at UT Southwestern Medical Center.

Released: 9-Jun-2023 3:25 PM EDT
Study shows metformin lowers the risk of getting long COVID
University of Minnesota Medical School

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

Released: 9-Jun-2023 1:35 PM EDT
Shed those pounds while digesting all these weight-loss research headlines from the Weight Loss channel
Newswise

As more families consider bariatric surgery a viable option to treat their child’s obesity, it is important to stay up-to-date on the latest research on weight loss. You can find the latest research on bariatric surgery and other weight loss options in the Weight Loss channel on Newswise, where journalists can find story ideas on this trending topic.

Newswise: ENDO 2023: Cedars-Sinai Experts Available for Interviews
Released: 8-Jun-2023 11:05 AM EDT
ENDO 2023: Cedars-Sinai Experts Available for Interviews
Cedars-Sinai

Cedars-Sinai endocrinologists will share their latest medical research and clinical care improvements at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, June 15-18.

Released: 8-Jun-2023 7:00 AM EDT
Usar IA para predecir la insuficiencia renal en pacientes con enfermedad renal poliquística
Mayo Clinic

La insuficiencia renal puede tener diversas causas: diabetes, presión arterial alta, enfermedades autoinmunitarias y enfermedad renal poliquística o ERP.

Released: 8-Jun-2023 7:00 AM EDT
Uso de IA para prever insuficiência renal em pacientes com doença renal policística
Mayo Clinic

A insuficiência renal pode ser causada por diversos motivos: diabetes, pressão arterial elevada, doenças autoimunes e doença renal policística ou DRP.



close
1.86465